233 related articles for article (PubMed ID: 17150416)
1. Electrochemotherapy of Mycosis fungoides by interferon-alpha.
Peycheva E; Daskalov I; Tsoneva I
Bioelectrochemistry; 2007 May; 70(2):283-6. PubMed ID: 17150416
[TBL] [Abstract][Full Text] [Related]
2. [Interferon-alpha and PUVA therapy for mycosis fungoides].
Marschalkó M; Kovács J; Somlai B; Berecz M; Hídvégi B; Hársing J; Désaknai M; Horváth A
Orv Hetil; 2001 Sep; 142(37):2021-3. PubMed ID: 11582733
[TBL] [Abstract][Full Text] [Related]
3. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
4. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
Roberge D; Muanza T; Blake G; Shustik C; Vuong T; Freeman CR
Br J Dermatol; 2007 Jan; 156(1):57-61. PubMed ID: 17199567
[TBL] [Abstract][Full Text] [Related]
5. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
6. [Topical application of ACNU for the treatment of mycosis fungoides].
Jimbow K; Horikoshi T; Kamimura M
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides.
Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S
Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093
[TBL] [Abstract][Full Text] [Related]
8. Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides.
Rupoli S; Goteri G; Pulini S; Filosa A; Tassetti A; Offidani M; Filosa G; Mozzicafreddo G; Giacchetti A; Brandozzi G; Cataldi I; Barulli S; Ranaldi R; Scortechini AR; Capretti R; Fabris G; Leoni P;
Eur J Haematol; 2005 Aug; 75(2):136-45. PubMed ID: 16000130
[TBL] [Abstract][Full Text] [Related]
9. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
Duvic M; Sherman ML; Wood GS; Kuzel TM; Olsen E; Foss F; Laliberté RJ; Ryan JL; Zonno K; Rook AH
J Am Acad Dermatol; 2006 Nov; 55(5):807-13. PubMed ID: 17052486
[TBL] [Abstract][Full Text] [Related]
10. [Seizures during interferon alpha therapy: three cases in dermatology].
Legroux-Crespel E; Lafaye S; Mahé E; Picard-Dahan C; Crickx B; Sassolas B; Descamps V
Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):202-4. PubMed ID: 12671585
[TBL] [Abstract][Full Text] [Related]
11. Granulomatous slack skin or granulomatous mycosis fungoides -- a case report. Complete response to percutaneous radiation and interferon alpha.
Wollina U; Graefe T; Füller J
J Cancer Res Clin Oncol; 2002 Jan; 128(1):50-4. PubMed ID: 11862472
[TBL] [Abstract][Full Text] [Related]
12. A patient with plaque-stage mycosis fungoides has successfully been treated with long-term administration of IFN-gamma and has been in complete remission for more than 6 years.
Horikoshi T; Onodera H; Eguchi H; Hanada N; Fukuzawa K; Takahashi M; Ishihara K; Ikeda S
Br J Dermatol; 1996 Jan; 134(1):130-3. PubMed ID: 8745899
[TBL] [Abstract][Full Text] [Related]
13. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
14. [Folliculotropic mycosis fungoides].
Baratli J; Balakirski G; Megahed M
Hautarzt; 2014 Dec; 65(12):1011-3. PubMed ID: 25355498
[TBL] [Abstract][Full Text] [Related]
15. Metastatic potential of melanoma cells is not affected by electrochemotherapy.
Todorovic V; Sersa G; Mlakar V; Glavac D; Flisar K; Cemazar M
Melanoma Res; 2011 Jun; 21(3):196-205. PubMed ID: 20216102
[TBL] [Abstract][Full Text] [Related]
16. Electrochemotherapy in treatment of tumours.
Sersa G; Miklavcic D; Cemazar M; Rudolf Z; Pucihar G; Snoj M
Eur J Surg Oncol; 2008 Feb; 34(2):232-40. PubMed ID: 17614247
[TBL] [Abstract][Full Text] [Related]
17. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
Dalle S; Thomas L
Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
[No Abstract] [Full Text] [Related]
18. Intralesional agents in the management of cutaneous malignancy: a review.
Good LM; Miller MD; High WA
J Am Acad Dermatol; 2011 Feb; 64(2):413-22. PubMed ID: 20334952
[TBL] [Abstract][Full Text] [Related]
19. Bexarotene monotherapy for patients with advanced stage mycosis fungoides.
Bachelez H
Dermatol Clin; 2008 Jan; 26 Suppl 1():25-6. PubMed ID: 18405183
[No Abstract] [Full Text] [Related]
20. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
